Helping you make wiser investment decisions

Pharmaceuticals, health and wellness

With J&J-partnered CAR-T nod in hand, Legend CEO eyes earlier myeloma use, cheaper cell therapy manufacturing

With J&J-partnered CAR-T nod in hand, Legend CEO eyes earlier myeloma use, cheaper cell therapy manufacturing aliu Tue, 03/08/2022 – 10:51 Source link

Gilead Sciences will lay off 114 staffers based out of former Immunomedics headquarters

Gilead Sciences will lay off 114 staffers based out of former Immunomedics headquarters esagonowsky Tue, 03/08/2022 – 10:48 Source link

J&J says it regrets injecting prisoners with asbestos, but such experiments were ‘widely accepted’ at the time

J&J says it regrets injecting prisoners with asbestos, but such experiments were ‘widely accepted’ at the time fkansteiner Tue, 03/08/2022 – 10:15 Source link

Moderna will provide access to mRNA tech, but high-income countries will have to pay

Moderna will provide access to mRNA tech, but high-income countries will have to pay kdunleavy Tue, 03/08/2022 – 09:43 Source link

Mass General plans study of nasally delivered binge eating disorder drug

Mass General plans study of nasally delivered binge eating disorder drug ntaylor Tue, 03/08/2022 – 08:50 Source link

FDA accelerated approvals targeted for revamp in House Energy and Commerce committee chair's new bill

FDA accelerated approvals targeted for revamp in House Energy and Commerce committee chair’s new bill fkansteiner Tue, 03/08/2022 – 08:43 Source link

And, exhale: Relief for Optinose as delivery system hits primary endpoints in chronic sinusitis phase 3

And, exhale: Relief for Optinose as delivery system hits primary endpoints in chronic sinusitis phase 3 ntaylor Tue, 03/08/2022 – 06:53 Source link

NuCana's twist on chemo drug Gemzar fails in phase 3 again

NuCana’s twist on chemo drug Gemzar fails in phase 3 again ntaylor Tue, 03/08/2022 – 06:46 Source link

Bottlenecks are slowing switch to GSK's long-acting HIV injectable Cabenuva: clinician

Bottlenecks are slowing switch to GSK’s long-acting HIV injectable Cabenuva: clinician ntaylor Tue, 03/08/2022 – 06:40 Source link

Bristol Myers Squibb's Revlimid finally faces competition in the U.S. with Teva's generic launch

Bristol Myers Squibb’s Revlimid finally faces competition in the U.S. with Teva’s generic launch kdunleavy Mon, 03/07/2022 – 11:18 Source link

Ukraine pharma CEO urges the industry to rally behind his country on three fronts

Ukraine pharma CEO urges the industry to rally behind his country on three fronts fkansteiner Mon, 03/07/2022 – 10:29 Source link

Bluebird Bio has 'doubts' about continuing to do business through 2021, announces CFO resignation

Bluebird Bio has ‘doubts’ about continuing to do business through 2021, announces CFO resignation kdunleavy Mon, 03/07/2022 – 09:24 Source link